1. A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment

   • Loredana G. Marcu
   • E. Yeoh

   Review 30 July 2009 Pages: 1303 - 1314

   

2. A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland

   • Hong He
   • Guanfu Chen
   • Yanmin Liu

   Original Paper 26 March 2009 Pages: 1315 - 1321

   

3. Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer

   • Wei-Qing Xu
   • Ling-Jun Song
   • Guo-Hui Fu

   Original Paper 28 March 2009 Pages: 1323 - 1330

   

4. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance

   • Guan Zhen Yu
   • Ying Chen
   • Jie Jun Wang

   Original Paper 01 April 2009 Pages: 1331 - 1339

   

5. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma

   • Xiaoya Yang
   • Gang Xiong
   • Yun Bai

   Original Paper 08 April 2009 Pages: 1341 - 1349

   

6. B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?

   • Petra Richter
   • Markus Tost
   • Alexander Berndt

   Original Paper 27 March 2009 Pages: 1351 - 1358

   

7. High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection

   • Jie Hu
   • Yang Xu
   • Jian Zhou

   Original Paper 07 April 2009 Pages: 1359 - 1367

   

8. ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma

   • Yao Jin
   • Zhang Quan Bin
   • Lan Qing

   Original Paper 02 April 2009 Pages: 1369 - 1376

   

9. Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo

   • Michael Pohl
   • I. Stricker
   • A. Reinacher-Schick

   Original Paper 02 April 2009 Pages: 1377 - 1386

   

10. Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma

    • Günter Emons
    • Rainer Kimmig

    Original Paper Open access 11 April 2009 Pages: 1387 - 1391

11. RETRACTED ARTICLE: Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer

    • Xiao-Chun Wang
    • Li-Li Tian
    • Ai-min Meng

    Original Paper 08 April 2009 Pages: 1393 - 1401

    

12. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China

    • Jia Fan
    • Guang-Shun Yang
    • Jian-Jun Zhang

    Original Paper 21 April 2009 Pages: 1403 - 1412

    

13. Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications

    • Hsi-Huang Tseng
    • Jan-Gowth Chang
    • Hsin-Su Yu

    Original Paper 23 April 2009 Pages: 1413 - 1420

    

14. Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

    • Takeshi Hara
    • Hisashi Tsurumi
    • Hisataka Moriwaki

    Original Paper 21 April 2009 Pages: 1421 - 1428

    

15. Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

    • Stefan Wilop
    • Sabine von Hobe
    • Edgar Jost

    Original Paper 28 April 2009 Pages: 1429 - 1435

    

16. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

    • Chong Zhong
    • Rong-ping Guo
    • Ya-qi Zhang

    Original Paper 01 May 2009 Pages: 1437 - 1445

    

17. The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma

    • Ning Zhang
    • Lu Wang
    • Zhao-You Tang

    Original Paper 28 April 2009 Pages: 1447 - 1453

    

18. Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model

    • Edwin Herrmann
    • Arne Tiemann
    • Christian Wülfing

    Original Paper 09 May 2009 Pages: 1455 - 1462

    

19. APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations

    • Per Arne Andresen
    • Ketil Heimdal
    • Tobias Gedde-Dahl Jr.

    Original Paper 15 May 2009 Pages: 1463 - 1470

    

20. APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations

    • Per Arne Andresen
    • Ketil Heimdal
    • Tobias Gedde-Dahl Jr.

    Erratum 30 June 2009 Pages: 1471 - 1471